Sedative agents, like GABAA-benzodiazepine (BZD) receptor agonists (muscimol, gaboxadol) and histamine H1 receptor (H1R) agonists (loratadine), are commonly explored for the treatment of insomnia. This evidence concerns the gene HRH1 and insomnia measurement.